COL1A1 and idiopathic pulmonary fibrosis: We then prepared PCLS from explanted IPF lungs and treated them with CB-1158 for 24 hours, followed by immunoblot for COL1A1 in the RIPA buffer–soluble fraction representing the more soluble, newly synthesized collagen (23).